Trial Profile
Safety and Efficacy of bimatoprost 0.03% in the Augmentation of Eyelashes of Korean Subjects
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 04 Jan 2016
Price :
$35
*
At a glance
- Drugs Bimatoprost (Primary)
- Indications Glaucoma; Ocular hypertension
- Focus Therapeutic Use
- Sponsors Allergan
- 31 Dec 2015 New trial record